Alimentiv Inc.

This study tests whether mirikizumab, an injected drug that blocks IL-23, can reduce inflammatory strictures (narrowed areas) in the small bowel caused by Crohn's disease. About 60 adults with at least one stricture will receive the drug and be monitored with MRI and symptom scor…

This study tests whether treating Crohn's disease with a goal of healing the entire gut wall (seen on ultrasound) leads to better results than treating based on symptoms and blood tests alone. About 304 adults with moderate to severe Crohn's will be split into two groups and foll…

This study tests whether a simple blood test that reads epigenetic markers can help doctors pick the best biologic drug (ustekinumab or vedolizumab) for adults with active Crohn's disease. 378 participants will be randomly assigned to either have their treatment guided by this te…

This study follows 300 adults with Crohn's disease who are starting standard treatments like vedolizumab or IL-23 blockers. Researchers will track how quickly patients feel improvements in pain, fatigue, and daily functioning using simple questionnaires. The goal is to better und…

This study involves about 50 adults with Crohn's disease who have a permanent ileostomy (a surgically created opening in the belly to pass waste). The goal is to create new tools—a patient questionnaire and an endoscopic scoring system—to accurately measure disease activity in th…